Prof. Dr. YUSUF TUTAR | AVESİS

Akademik Veri Yönetim Sistemi

Yayınlar & Eserler

Makaleler 111

1. Phytochemical profiling and anticancer potential of pistachio wastes against MCF-7 breast cancer cells: a metabolic and apoptotic pathway analysis

Gülüm L., Güler E., Zırhlı Ç. B., Çelik A. B., TUTAR Y.

BMC Complementary Medicine and Therapies , cilt.25, sa.1, 2025 (SCI-Expanded)

2. Synthesis, Characterization, and Screening Anticancer-Antibiofilm Activities of Theophylline Derivatives Containing CF₃/OCF₃ Moiety

Dusunceli S. D., Coskun K. A., KALOĞLU M., Ustun E., ÇALIŞKAN R., TUTAR Y.

BIOLOGY-BASEL , cilt.14, sa.9, 2025 (SCI-Expanded)

3. Investigation of Anticancer Properties of Newly Synthesized Pyridazine-Based Inhibitors in Mouse and Human Breast Cancer Cell Line

Coskun K. A., Abay E. C., Gumus M., Celik A. B., Gulum L., KOCA İ., et al.

BIOLOGY-BASEL , cilt.14, sa.9, 2025 (SCI-Expanded)

4. **Anticancer Activity of Vitex agnus-castus Seed Extract on Gastric Cancer Cells**

Turksoy-Terzioglu O., Tosya F., Celik A. B., Bolek S., Gulum L., Terzioglu G., et al.

NUTRIENTS , cilt.17, sa.15, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

5. Syntheses and Identification of New Dithiophosphinic Acid Complexes and Their Potential as Photodynamic Agents in Cancer Therapy.

Coşkun K. A., Bulat E., Yılmaz H., Sağlam E. G., Tutar L., Ur Rehman F., et al.

Medicinal chemistry (Shariqah (United Arab Emirates)) , sa.1, 2025 (SCI-Expanded)

6. **In Vitro Effects of Rumex confertus Extracts on Cell Viability and Molecular Pathways in MCF-7 Breast Cancer Cells**

Gulum L., Guler E., Aktas F. L., Celik A. B., YILMAZ H., Tutar Y.

ANTIOXIDANTS , cilt.14, sa.7, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

7. MEME KANSERİ HÜCRESİNDE METİLEN MAVİSİ ARACİLİ FOTODİNAMİK TERAPİ VE DOKSORUBİSİNİN KOMBİNASYONEL ETKİSİ

Coskun K. A., abay e. c., Tutar L., TUTAR Y.

Acta Medica Nicomedia , cilt.8, sa.2, ss.113-120, 2025 (Hakemli Dergi)

8. Boron-doped carbon quantum dots: A biocompatible nanoplatform for targeted cancer theranostics

Güven G. K., Okur M. E., Ayla Ş., Çalışkan G., Al M. N., Gülüm L., et al.

International Journal of Pharmaceutics , cilt.679, 2025 (SCI-Expanded)

9. Prognostic value of Aurora B expression in cancer patients: A meta-analysis

Hasan M. M., Tory S., ARSLAN Y. K., SAYGIDEĞER Y., TUTAR Y.

Tumori , cilt.111, sa.3, ss.253-260, 2025 (SCI-Expanded)

10. Design, Synthesis, and Evaluation of Benzimidazole-Carbazole Hybrids Targeting Heat Shock Proteins-Mediated Apoptosis in Breast and Colon Cancer Cells

ÇAPAN İ., Al M., GÜMÜŞ M., AÇIK L., AYDIN B., Çelik A. B., et al.

Drug Development Research , cilt.86, sa.3, 2025 (SCI-Expanded)

11. Metabolite-Induced Apoptosis by Gundelia tournefortii in A549 Lung Cancer Cells: A Cytotoxic and Gene Expression Study

Yuksel A., Celayir D. N., Yenilmez Tunoglu E. N., Tutar L., TUTAR Y.

Nutrients , cilt.17, sa.3, 2025 (SCI-Expanded)

12. The role of 1-Deoxysphingolipids and Polyamines in the pathogenesis of placental syndrome

Guleroglu F. Y., Cetin A., COŞKUN G. P., Caliskan M., Karaduman F., Bilginer C., et al.

BMC pregnancy and childbirth , cilt.25, sa.1, ss.51, 2025 (SCI-Expanded)

13. HSP Inhibitor Sensitize Resistant MCF-7 Cells to Doxorubicin through Suppressing HSP90AB4P Pseudogene and HSPB1 Expression

Coşkun K. A., Tutar L., Abay E. C., Gülüm L., Çelik A. B., GÜMÜŞ M., et al.

Anti-Cancer Agents in Medicinal Chemistry , 2025 (SCI-Expanded)

14. Exploring the bioremediation potential of nonpathogenic Pb-resistant strain Klebsiella pneumoniae in Oreochromis niloticus

Zafar S., Ashraf A., Asad F., Muzammil S., Ahmad K., Sultana S., et al.

Bioremediation Journal , 2025 (SCI-Expanded)

15. How to Expedite Drug Discovery: Integrating Innovative Approaches to Accelerate Modern Drug Development

Besli N., Ercin N., Celik U., Tutar Y.

ACTA CHIMICA SLOVENICA , cilt.72, sa.3, ss.581-600, 2025 (SCI-Expanded)

16. Non-genetic heterogeneity and immune subtyping in breast cancer: Implications for immunotherapy and targeted therapeutics.

Hassan M., Tutar L., Sari-Ak D., Rasul A., Basheer E., Tutar Y.

Translational oncology , cilt.47, ss.102055, 2024 (SCI-Expanded)

17. Synthesis of novel carbazole hydrazine-carbothioamide scaffold as potent antioxidant, anticancer and antimicrobial agents

ÇAPAN İ., Hawash M., Qaoud M. T., Gulum L., Tunoglu E. N. Y., Cifci K. U., et al.

BMC CHEMISTRY , cilt.18, sa.1, 2024 (SCI-Expanded)

Creative Commons License

Sürdürülebilir Kalkınma

18. Hsp Inhibitor is Affective Against Adenocarcinomic Human Alveolar Basal Epithelial Cells Through Modulating ERK/MAPK Signaling Pathway

Tunoglu S., Tutar L., GÜMÜŞ M., Tunoglu E. N. Y., KOCA İ., Tutar Y.

CHEMISTRY & BIODIVERSITY , cilt.21, sa.2, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

19. Metabologenomics and network pharmacology to understand the molecular mechanism of cancer research

WORLD JOURNAL OF CLINICAL CASES , cilt.12, sa.3, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

20. Pralatrexate for Peripheral T-Cell Lymphoma (PTCL): Chance Only Supports The Prepared Mind

Altınay S., Kural A., Özmen A., Tural D., TUTAR Y.

Anti-Cancer Agents in Medicinal Chemistry , cilt.23, sa.3, ss.298-305, 2023 (SCI-Expanded)

21. Triad pyrazole–thiazole–coumarin heterocyclic core effectively inhibit HSP and drive cancer cells to apoptosis

GÜMÜŞ M., KOCA İ., SERT Y., DİŞLİ A., Yenilmez Tunoğlu E. N., Tutar L., et al.

Journal of Biomolecular Structure and Dynamics , cilt.41, sa.23, ss.14382-14397, 2023 (SCI-Expanded)

22. Editorial: MicroRNA-related polymorphisms in infectious and inherited diseases

TUTAR Y., PİRİM D., Shah A. A., Vallinoto A. C. R.

Frontiers in Genetics , cilt.14, 2023 (SCI-Expanded)

Creative Commons License

23. Noncoding RNAs in Cancer Theranostics: From Molecular Basis to Therapeutic Implications

Current Pharmaceutical Biotechnology , cilt.24, sa.7, 2023 (SCI-Expanded)

24. Involvement of Metabolites and Non-coding RNAs in Diseases

Coskun K. A., Kıyak B. Y., Cifci K. U., Kadioglu E., Yurekli N., TUTAR Y.

Current Pharmaceutical Biotechnology , cilt.24, sa.7, ss.889-912, 2023 (SCI-Expanded)

25. A Novel 6,8,9-Trisubstituted Purine Analogue Drives Breast Cancer Luminal A Sub-type MCF-7 to Apoptosis and Senescence through Hsp70 Inhibition

KUL P., TUNÇBİLEK M., ERGÜL M., Tunoglu E. N. Y., TUTAR Y.

Anti-Cancer Agents in Medicinal Chemistry , cilt.23, sa.5, ss.585-598, 2023 (SCI-Expanded)

26. Synthesis and Characterization of Novel Calix[4]arene Schiff Base Derivatives and Cytotoxicity Effect Evaluation on Cancer Cell Lines

IŞIK A., UÇAR ÇİFÇİ K., BOSTANCI H. E., TUTAR Y., KOÇAK A., YILMAZ M.

CUMHURIYET SCIENCE JOURNAL , cilt.43, 2022 (Hakemli Dergi)

27. Silver(I) Complexes Based on Oxadiazole-Functionalized α-Aminophosphonate: Synthesis, Structural Study, and Biological Activities

Hkiri S., Coşkun K. A., Üstün E., Samarat A., TUTAR Y., ŞAHİN N., et al.

Molecules , cilt.27, sa.23, 2022 (SCI-Expanded)

28. A Medium for Facilitating Hepatitis B Virus Detection and Replication of the Virus.

KARİPER İ. A., Demir T., BAHAR D., HEPOKUR C., Caner A., ÖNAL M. G., et al.

Research & Reviews: Research Journal of Biology , 2022 (Hakemli Dergi)

29. Pyrazolyl-Benzoxazinone Derivatives as Dual Hsp Inhibitors in Human Breast Cancer

KOCA İ., Kamaci V., ÖZSOY C., SERT Y., Kani İ., Tutar L., et al.

ChemistrySelect , cilt.7, sa.19, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

30. Computational Analysis of Drug Resistance Network in Lung Adenocarcinoma

Kara A., Özgür A., Tekin Ş., TUTAR Y.

Anti-Cancer Agents in Medicinal Chemistry , cilt.22, sa.3, ss.566-578, 2022 (SCI-Expanded)

31. Critical Residues in Hsp70 Nucleotide Binding Domain for Challenges in Drug Design

ERGÜL M., AKTAN F., TUTAR Y.

Current Proteomics , cilt.19, sa.1, ss.83-90, 2022 (SCI-Expanded)

32. MicroRNA Targeting.

Ghanbarian H., Yıldız M. T., Tutar Y.

Methods in molecular biology (Clifton, N.J.) , cilt.2257, ss.105-130, 2022 (Scopus)

33. MicroRNAs and Heat Shock Proteins in Breast Cancer Biology.

Yildiz M. T., Tutar L., Giritlioğlu N. I., Bayram B., Tutar Y.

Methods in molecular biology (Clifton, N.J.) , cilt.2257, ss.293-310, 2022 (Scopus)

34. 44 Current Challenges in miRNomics.

Akgül B., Stadler P. F., Hawkins L. J., Hadj-Moussa H., Storey K. B., Ergin K., et al.

Methods in molecular biology (Clifton, N.J.) , cilt.2257, ss.423-438, 2022 (Scopus)

35. ATPase inhibition by omeprazole reveals role of heat shock proteins on testicular torsion

GÜNEY C., Coşkun K. A., TUTAR Y.

Andrologia , cilt.53, sa.2, 2021 (SCI-Expanded)

36. Designing specific hsp70 substrate binding domain inhibitor for perturbing protein folding pathways to inhibit cancer mechanism

Coşkun K. A., KOCA İ., GÜMÜŞ M., TUTAR Y.

Anti-Cancer Agents in Medicinal Chemistry , cilt.21, sa.11, ss.1472-1480, 2021 (SCI-Expanded)

37. Performance of capecitabine in novel combination therapies in colorectal cancer

Pouya F. D., Rasmi Y., Camci I. Y., TUTAR Y., Nemati M.

Journal of Chemotherapy , cilt.33, sa.6, ss.375-389, 2021 (SCI-Expanded)

38. Short Commentary on "Targeting Long Non-Coding RNAs in Nervous System Cancers: New Insights in Prognosis, Diagnosis, and Therapy"

CURRENT MEDICINAL CHEMISTRY , cilt.27, sa.42, ss.7289-7292, 2020 (SCI-Expanded)

39. Assessment of plasma and tissue fibronectin eiiib splice variant expressions measured serially using RT-PCR in a wound model of rabbits Tavşan yara modelinde RT-PCR yöntemi ile seri olarak ölçülen plazma ve doku fibronektin eiiib splice değerlerinin ölçümleri

Özkaya N. K., Zereyak U., Coşkun K. A., TUTAR Y., Yılmaz S.

Ulusal Travma ve Acil Cerrahi Dergisi , cilt.26, sa.4, ss.497-502, 2020 (SCI-Expanded)

Creative Commons License

40. Perturbation of hsp network in mcf-7 breast cancer cell line triggers inducible hsp70 expression and leads to tumor suppression

ERGÜL M., AKTAN F., Yildiz M. T., TUTAR Y.

Anti-Cancer Agents in Medicinal Chemistry , cilt.20, sa.9, ss.1051-1060, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

41. The role of cysteine cathepsins in cancer progression and drug resistance

Rudzińska M., Parodi A., Soond S. M., Vinarov A. Z., Korolev D. O., Morozov A. O., et al.

International Journal of Molecular Sciences , cilt.20, sa.14, 2019 (SCI-Expanded)

42. Non-coding RNAs in lung cancer

Tutar E., TUTAR Y.

Journal of Thoracic Disease , cilt.11, 2019 (SCI-Expanded)

43. NUTRIENTS, BIOACTIVE COMPOUNDS, AND HEALTH BENEFITS OF FUNCTIONAL AND MEDICINAL BEVERAGES

Yilmaz-Akyuz E., Ustun-Aytekin O., Bayram B., Tutar Y.

NUTRIENTS IN BEVERAGES , cilt.12, ss.175-235, 2019 (Hakemli Dergi)

44. Determination of Optimum Operation Parameters for Low-Intensity Pulsed Ultrasound and Low-Level Laser Based Treatment to Induce Proliferation of Osteoblast and Fibroblast Cells

Coskun M. E., Coskun K. A., TUTAR Y.

Photomedicine and laser surgery , cilt.36, sa.5, ss.246-252, 2018 (SCI-Expanded)

45. N-Acetyl Cysteine and Metal Nanoparticles Internalization: A Critical Methodological Aspect

Gholinejad Z., Ghasemian A., TUTAR Y., Saboory E., Rasmi Y.

JOURNAL OF BIONANOSCIENCE , cilt.12, ss.1-5, 2018 (Hakemli Dergi)

46. Involvement of miRNAs and Pseudogenes in Cancer.

Tutar L., Özgür A., Tutar Y.

Methods in molecular biology (Clifton, N.J.) , cilt.1699, ss.45-66, 2018 (Scopus)

47. Tumor targeting of polymeric nanoparticles conjugated with peptides, saccharides, and small molecules for anticancer drugs

Bayram B., Özgür A., Tutar L., TUTAR Y.

Current Pharmaceutical Design , cilt.23, sa.35, ss.5349-5357, 2017 (SCI-Expanded)

48. Anticancer activities of manganese-based photoactivatable CO-releasing complexes (PhotoCORMs) with benzimidazole derivative ligands

Üstün E., Özgür A., Coşkun K. A., DEMİR DÜŞÜNCELİ S., ÖZDEMİR İ., TUTAR Y.

Transition Metal Chemistry , cilt.42, sa.4, ss.331-337, 2017 (SCI-Expanded)

49. Oxidative Stress in Metabolic Disorders and Drug-Induced Injury: The Potential Role of Nrf2 and PPARs Activators

Mahmoud A. M., Alexander M. Y., TUTAR Y., Wilkinson F. L., Venditti A.

Oxidative Medicine and Cellular Longevity , cilt.2017, 2017 (SCI-Expanded)

50. Effect of New Water-Soluble Dendritic Phthalocyanines on Human Colorectal and Liver

YABAŞ E., SÜLÜ M., Aykut Ö., TUTAR Y.

Journal of Natural and Applied Sciences , cilt.21, sa.2, ss.689-695, 2017 (Hakemli Dergi)

51. CO-releasing properties and anticancer activities of manganese complexes with imidazole/benzimidazole ligands

Üstün E., Özgür A., Coşkun K. A., Demir S., ÖZDEMİR İ., TUTAR Y.

Journal of Coordination Chemistry , cilt.69, sa.22, ss.3384-3394, 2016 (SCI-Expanded)

52. Structure-function based drug design for cancer therapeutics

Current Pharmaceutical Biotechnology , cilt.17, sa.14, ss.1200, 2016 (SCI-Expanded)

53. Design, synthesis, and evaluation of heat shock protein 90 inhibitors in human breast cancer and its metastasis

GÜMÜŞ M., Ozgur A., Tutar L., DİŞLİ A., KOCA İ., TUTAR Y.

Current Pharmaceutical Biotechnology , cilt.17, sa.14, ss.1231-1245, 2016 (SCI-Expanded)

54. Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer

TUTAR Y., Özgür A., Tutar E., Tutar L., Pulliero A., Izzotti A.

Biomedicine and Pharmacotherapy , cilt.83, ss.1182-1190, 2016 (SCI-Expanded)

55. Heat shock protein 90 inhibition in cancer drug discovery: From chemistry to futural clinical applications

Özgür A., TUTAR Y.

Anti-Cancer Agents in Medicinal Chemistry , cilt.16, sa.3, ss.280-290, 2016 (SCI-Expanded)

56. Nutraceuticals and Its Therapeutic Applications

Advanced Techniques in Biology and Medicine , cilt.4, sa.2, ss.1, 2016 (Hakemli Dergi)

57. Structure Based Drug Design for Heat Shock Proteins

TUTAR L., Coşkun K. A., TUTAR Y.

Drug Designing , cilt.5, sa.2, ss.1-2, 2016 (Hakemli Dergi)

58. Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis

KOCA İ., Özgür A., ER M., GÜMÜŞ M., Coşkun K. A., TUTAR Y.

European Journal of Medicinal Chemistry , cilt.122, ss.280-290, 2016 (SCI-Expanded)

59. Editor s Note

Drug Designing , cilt.5, sa.3, ss.1, 2016 (Hakemli Dergi)

60. Heat Shock Protein as Emerging Oncologic Drug Targets

TUTAR L., Coşkun K. A., TUTAR Y.

Journal of Developing Drugs , cilt.5, sa.2, ss.1-2, 2016 (Hakemli Dergi)

61. Editor Note

Single Cell Biology , cilt.5, sa.2, ss.1-2, 2016 (Hakemli Dergi)

62. New Generation Cancer Drug Studies Hsp90 Inhibitors

TUTAR L., Coşkun K. A., TUTAR Y.

Single Cell Biology , 2016 (Hakemli Dergi)

63. Current Drug Design Studies for Hsp70 in Oncological Applications

Coşkun K. A., TUTAR L., TUTAR Y.

Cell & Developmental Biology , cilt.5, sa.2, ss.1-2, 2016 (Hakemli Dergi)

64. Drug Dependent Stress and Heat ShockProtein Response

TUTAR L., Coskun K. A., TUTAR Y.

Journal of Drug Abbuse , cilt.2, sa.28, ss.1-3, 2016 (Hakemli Dergi)

65. Therapeutic Targeting of microRNAs in Cancer: Future Perspectives

Tutar L., Tutar E., Özgür A., TUTAR Y.

Drug Development Research , cilt.76, sa.7, ss.382-388, 2015 (SCI-Expanded)

66. A novel approach to inhibit heat shock response as anticancer strategy by coumarine compounds containing thiazole skeleton

KOCA İ., GÜMÜŞ M., Özgür A., DİŞLİ A., TUTAR Y.

Anti-Cancer Agents in Medicinal Chemistry , cilt.15, sa.7, ss.916-930, 2015 (SCI-Expanded)

67. Isolation and characterization of Heat Shock Protein 100-Batu1 from Toxoplasma gondii RH strain

Coşkun K. A., TUTAR Y.

Experimental Parasitology , cilt.153, ss.91-97, 2015 (SCI-Expanded)

68. Synthesis, molecular docking, and antitumoral activity of alnustone-like compounds against estrogen receptor alpha-positive human breast cancer

Glu K. K. Ü., Inti H. S., Özgür A., SEÇEN H., TUTAR Y.

Turkish Journal of Chemistry , cilt.39, sa.1, ss.179-193, 2015 (SCI-Expanded)

69. Acyl Thiourea Derivatives Containing Pyrazole Ring Selective Targeting of Human Aurora Kinases in Breast and Bone Cancer

Özgür A., Yenidünya E., Koca I., Tutar Y.

LETTERS IN DRUG DESIGN & DISCOVERY , cilt.12, sa.3, ss.180-189, 2015 (SCI-Expanded)

70. miRNA and cancer; computational and experimental approaches

Current Pharmaceutical Biotechnology , cilt.15, sa.5, ss.429, 2014 (SCI-Expanded)

71. MicroRNAs and cancer; an overview

Tutar L., Tutar E., TUTAR Y.

Current Pharmaceutical Biotechnology , cilt.15, sa.5, ss.430-437, 2014 (SCI-Expanded)

72. Editorial

Protein and Peptide Letters , cilt.21, sa.11, ss.1085-1086, 2014 (SCI-Expanded)

73. Effect of strontium chloride on experimental bladder inflammation in rat

KORĞALI E., Dundar G., Coskun K. A., AKYOL M., TUTAR Y., Ayan S., et al.

ISRN Urology , cilt.2014, 2014 (Scopus)

74. Correlations between the expression levels of micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers

Acibucu F., Dökmetaś H., TUTAR Y., Elagoz Ş., Kilicli F.

Experimental and Clinical Endocrinology and Diabetes , cilt.122, sa.3, ss.137-143, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

75. “Prion; Mechanism and function”

Current Pharmaceutical Biotechnology , cilt.15, sa.11, ss.1007, 2014 (SCI-Expanded)

76. Regulation of Heat Shock Proteins by miRNAs in human breast cancer.

Ozgur A., Tutar L., Tutar Y.

MicroRNA (Shariqah, United Arab Emirates) , cilt.3, sa.2, ss.118-35, 2014 (Hakemli Dergi)

77. Heat shock protein 90 inhibitors in oncology

Özgür A., TUTAR Y.

Current Proteomics , cilt.11, sa.1, ss.2-16, 2014 (SCI-Expanded)

78. Important anti-cancer applications of protein based nanoparticles

ERGÜL M., Ergül M., TUTAR Y.

Current Proteomics , cilt.10, sa.4, ss.334-340, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

79. The role of preoperative oxidative stress and mandibular third molar postoperative outcome

Gülnahar Y., Köşger H., TUTAR Y.

International Journal of Oral and Maxillofacial Surgery , cilt.42, sa.11, ss.1500-1501, 2013 (SCI-Expanded)

80. Isolation and identification of free-living amoebae from tap water in Sivas, Turkey

Coşkun K. A., Özçelik S., Tutar L., ELALDI N., TUTAR Y.

BioMed Research International , cilt.2013, 2013 (SCI-Expanded)

81. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety

KOCA İ., Özgür A., Coşkun K. A., TUTAR Y.

Bioorganic and Medicinal Chemistry , cilt.21, sa.13, ss.3859-3865, 2013 (SCI-Expanded)

82. A comparison of piezosurgery and conventional surgery by heat shock protein 70 expression

Gülnahar Y., Hüseyin Köşger H., TUTAR Y.

International Journal of Oral and Maxillofacial Surgery , cilt.42, sa.4, ss.508-510, 2013 (SCI-Expanded)

83. Therapeutic proteins: A to Z

Özgür A., TUTAR Y.

Protein and Peptide Letters , cilt.20, sa.12, ss.1365-1372, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

Sürdürülebilir Kalkınma

84. Dynamic Fluctuations Provide the Basis of a Conformational Switch Mechanism in Apo Cyclic AMP Receptor Protein

Aykaç Fas B., TUTAR Y., Haliloǧlu T.

PLoS Computational Biology , cilt.9, sa.7, 2013 (SCI-Expanded)

85. Heat shock protein 40-Gok1 isolation from Toxoplasma gondii RH strain

Coşkun K. A., Özgür A., Otauǧ B., Mungan M., TUTAR Y.

Protein and Peptide Letters , cilt.20, sa.12, ss.1294-1301, 2013 (SCI-Expanded)

86. Editorial Drug Candidates for Heat Shock Protein 90 Inhibition

Drug Designing , cilt.3, sa.1, ss.1, 2013 (Hakemli Dergi)

87. Editorial

Protein and Peptide Letters , cilt.20, sa.12, ss.1293, 2013 (SCI-Expanded)

88. Hsp70 from Cyprinion macrostomus macrostomus and Garra rufa obtuse: Stability and stability-dependent activity

TUTAR Y., Coskun K., Tutar L.

Biochemistry (Moscow) , cilt.78, sa.5, ss.531-535, 2013 (SCI-Expanded)

89. Pseudogenes

Comparative and Functional Genomics , cilt.2012, 2012 (SCI-Expanded)

90. Neglected role of cAMP receptor protein monomer

Molecular Biology Reports , cilt.39, sa.4, ss.4261-4265, 2012 (SCI-Expanded)

91. Heat shock protein 70 purification and characterization from Cyprinion macrastomus macrastomus and Garra rufa obtusa

TUTAR Y., Okan Ş.

Journal of Thermal Biology , cilt.37, sa.1, ss.95-99, 2012 (SCI-Expanded)

92. Hsp70 in oncology

Recent Patents on DNA and Gene Sequences , cilt.5, sa.3, ss.214-218, 2011 (Scopus)

93. Ssa1 function in the presence of nucleotide and Ssa1 oligomeric properties

Cumhuriyet Medical Journal , cilt.33, ss.26-32, 2011 (Hakemli Dergi)

94. Therapeutic use of heat shock proteins and essential factors in prognosis, diagnosis and treatment of neurodegenerative and metabolic diseases

Current Pharmaceutical Biotechnology , cilt.11, sa.2, ss.138, 2010 (SCI-Expanded)

95. Heat shock proteins; An overview

Tutar L., TUTAR Y.

Current Pharmaceutical Biotechnology , cilt.11, sa.2, ss.216-222, 2010 (SCI-Expanded)

96. Heat, pH induced aggregation and surface hydrophobicity of S. cerevesiae ssa1 protein

TUTAR Y., Arslan D., Tutar L.

Protein Journal , cilt.29, sa.7, ss.501-508, 2010 (SCI-Expanded)

97. Yeast Prions

Basic and Clinical Sciences , sa.1, ss.45-51, 2010 (Hakemli Dergi)

98. Protein & Peptide Letters: Editorial

Protein and Peptide Letters , cilt.16, sa.6, ss.570, 2009 (SCI-Expanded)

99. Syn, anti, and finally both conformations of cyclic AMP are involved in the CRP-dependent transcription initiation mechanism in E. coli lac operon

Cell Biochemistry and Function , cilt.26, sa.4, ss.399-405, 2008 (SCI-Expanded)

100. Ydj1 but not Sis1 stabilizes Hsp70 protein under prolonged stress in vitro

Tutar L., TUTAR Y.

Biopolymers , cilt.89, sa.3, ss.171-174, 2008 (SCI-Expanded)

101. Chemical linkage at allosteric activation of E. coli cAMP receptor protein

Protein Journal , cilt.27, sa.1, ss.21-29, 2008 (SCI-Expanded)

102. Therapeutic use of Heat Shock Protein 70.

Recent patents on DNA & gene sequences , cilt.1, sa.2, ss.125-127, 2007 (Scopus)

103. CRP subunit association and hinge conformation changes in response to cAMP binding: Analysis of C-helix cysteine-substituted CRP

Tomlinson S. R., TUTAR Y., Harman J. G.

Biochemistry , cilt.45, sa.45, ss.13438-13446, 2006 (SCI-Expanded)

104. Effect of salt bridge on transcription activation of CRP-dependent lactose operon in Escherichia coli

TUTAR Y., Harman J. G.

Archives of Biochemistry and Biophysics , cilt.453, sa.2, ss.217-223, 2006 (SCI-Expanded)

105. Key residues involved in Hsp70 regulatory activity and affect of co-chaperones on mechanism of action

Protein and Peptide Letters , cilt.13, sa.7, ss.693-698, 2006 (SCI-Expanded)

106. Heat shock proteins, substrate specificity and modulation of function

Protein and Peptide Letters , cilt.13, sa.7, ss.699-705, 2006 (SCI-Expanded)

107. Dimerization and ion binding properties of S100P protein

Protein and Peptide Letters , cilt.13, sa.3, ss.301-306, 2006 (SCI-Expanded)

108. Target peptide recognition by S100P protein and role of central linker region and dimer interface

Protein and Peptide Letters , cilt.13, sa.3, ss.307-311, 2006 (SCI-Expanded)

109. Primate chaperones Hsc70 (constitutive) and Hsp70 (induced) differ functionally in supporting growth and prion propagation in Saccharomyces cerevisiae

TUTAR Y., Song Y., Masison D. C.

Genetics , cilt.172, sa.2, ss.851-861, 2006 (SCI-Expanded)

110. Role for Hsp70 chaperone in Saccharomyces cerevisiae prion seed replication

Song Y., Wu Y., Jung G., TUTAR Y., Eisenberg E., Greene L. E., et al.

Eukaryotic Cell , cilt.4, sa.2, ss.289-297, 2005 (SCI-Expanded)

111. Interaction of CRP L124 with cAMP affects CRP cAMP binding constants, cAMP binding cooperativity, and CRP allostery

Tomlinson S. R., TUTAR Y., Harman J. G.

Biochemistry , cilt.42, sa.13, ss.3759-3765, 2003 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 38

1. Heat Shock Proteins: Boon od A Bane in Cancer Mechanism.

TUTAR Y., KOCA İ.

Chemistry and Medicine from Theory to Practice Scientific and Practical Conference, 07 Ekim 2022, (Tam Metin Bildiri)

2. Heat Shock Protein Inhibitors Leads Apoptosis of Senescent Cells in Lung Cancer Cells

4th International Conference on Applied Zoology-2021, Islamabad, Pakistan, 24 - 25 Kasım 2021, (Özet Bildiri)

3. Targeting Heat Shock Proteins: The Next Generation Agents of Breast Cancer Treatment

VIII. International Congress of Molecular Medicine, İstanbul, Türkiye, 09 Kasım 2021, (Özet Bildiri)

4. An effective drug design for anticancer treatment: Hsp inhibitors

The 3rd International Conference on Applications in Chemistry and Chemical Engineering (ICACChE), 11 - 15 Eylül 2019, (Tam Metin Bildiri)

5. SITE-DIRECTED MUTATIONS ON HSP70 NBD DECREASE THEPROTEIN FOLDING FUNCTION

ERGÜL M., AKTAN F., TUTAR Y.

Gazi Pharma Symposium, 11 - 13 Ekim 2017, (Özet Bildiri)

6. CYTOTOXIC EFFECTS OF HSP70 INHIBITORS MKT-077 ANDVER-155008 ON BREAST CANCER CELLS MCF-7

ERGÜL M., AKTAN F., TUTAR Y.

Gazi Pharma Symposium, 11 - 13 Ekim 2017, (Özet Bildiri)

7. HSP70 INHIBITOR PES, DOWN-REGULATE SEVERALCANCER-RELATED GENES ON BREAST CANCER CELLS

ERGÜL M., AKTAN F., TUTAR Y.

Gazi Pharma Symposium Series, 11 Ekim 2017 - 13 Ekim 2018, (Özet Bildiri)

8. Benzodiazepine Inhibitors as Anticancer Agents Against Human Breast Cancer

TUTAR Y., KOCA İ.

COST ACTION CM1407, 21 - 22 Eylül 2017, (Özet Bildiri)

9. Interacting Network Macromolecules between Cytosol and Mitochondria in Cancer Cells

TUTAR L., TUTAR Y., tutar e.

INTERNATIONAL DNA DAY AND GENOME CONGRESS, 24 - 28 Nisan 2017, (Tam Metin Bildiri)

10. Cotton MicroRNAs.

TUTAR L., TUTAR Y., TUTAR E., KARAMAN Ş.

International DNA Day and Genome Congress, 24 - 28 Nisan 2017, (Özet Bildiri)

11. Heat Shock Proteins in Toxoplasma gondii Survival Factors

TUTAR L., TUTAR Y., akıncı k. s.

International DNA Day and Genome Kongress, 24 - 28 Nisan 2017, (Özet Bildiri)

12. Small Molecule Inhibition Strategy Among Coordinating and Cooperating Chaperones

International DNA Day and Genome Congress, 24 - 28 Nisan 2017, (Özet Bildiri)

13. Pseudogenes and miRNAs in Different Cancer Types

TUTAR Y., tutar e.

International DNA Day and Genome Congress, 24 - 28 Nisan 2017, (Özet Bildiri)

14. Pseudogenes and Apoptosis in Cancer

International DNA Day and Genome Congress, 24 - 28 Nisan 2017, (Özet Bildiri)

15. Tiyazol-Kumarin, Tiyazol-Diazepin ve Tiyazol-Pirazol-Kumarin HalkaSistemlerini İçeren Heterosiklik Bileşiklerin HSP70 ve HSP90 İnhibitör Özelliklerinin İncelenmesi

GÜMÜŞ M., KOCA İ., DİŞLİ A., Aykut Ö., Açıkalın Coşkun K., TUTAR Y.

Uluslararası Katılımlı5. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi,Üretimi ve Standardizasyonu Kongresi, Antalya, Türkiye, 30 Mart - 02 Nisan 2017, (Özet Bildiri)

16. Potansiyel Biyoaktif Heterosiklik Keten Aminal Türevi Pirazol-Perimidin Hibrit Bileşiklerinin Sentezi

KOCA İ., GÜMÜŞ M., Açıkalın Coşkun K., TUTAR Y.

Uluslararası Katılımlı 5. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi, Üretimi ve Standardizasyonu Kongresi, Antalya, Türkiye, 30 Mart - 02 Nisan 2017, (Özet Bildiri)

17. Heteroaromatik Gruplar İçeren Hibrit Yapılı HSP İnhibitörleri

KOCA İ., GÜMÜŞ M., Aykut Ö., Açıkalın Coşkun K., Hepokur C., TUTAR Y.

Uluslararası Katılımlı5. İlaç Kimyası: İlaç Etkin Maddesi Tasarımı, Sentezi,Üretimi ve Standardizasyonu Kongresi, Antalya, Türkiye, 30 Mart - 02 Nisan 2017, (Özet Bildiri)

18. Anticancer activities of COST plant extracts in target specific cancer chemotherapy

TUTAR Y., aykut ö.

NATCHEM 3rd Meeting, 2 - 03 Mart 2017, (Özet Bildiri)

19. Heat Shock Proteins in Targeted Cancer Chemotherapy

TUTAR Y., Aykut Ö.

2nd International Electronic Conference on Medicinal Chemistry, 1 - 30 Ekim 2016, (Tam Metin Bildiri)

20. Dual targeting of Hsp70 and Hsp90 with pyrimidinyl acyl thiourea inhibitors

Coskun K. A., GÜMÜŞ M., KOCA İ., TUTAR Y.

COST Action CM1407 1ST TRAINING SCHOOL, 24 - 26 Eylül 2016, (Tam Metin Bildiri)

21. Enfektif T gondii RH Suşundan Isı Şok Proteini 70 in tgHsp70 İzolasyonu ve Karakterizasyonu

TUTAR L., Coşkun K. A., TUTAR Y., Tutar E., Aykut Ö.

23. Ulusal Biyoloji Kongresi, Türkiye, 5 - 09 Eylül 2016, (Tam Metin Bildiri)

22. Analysis of molecular cytogenetic alterations in gastric and colon carcinoma by array-based comparative genomic hybridization (Array CGH)

Bagci B., Karadayi K., Ozer H., Tuncer E., Tutar Y., Sezgin I., et al.

cilt.283, ss.161, (Özet Bildiri)

23. Inhibition Studies of Novel Coumarine Derivaties as Hsp90 and Hsp70 Inhibitors

GÜMÜŞ M., KOCA İ., coşkun K. A., TUTAR Y., DİŞLİ A.

Euroasian Biodiversity, 23 - 27 Mayıs 2016, (Tam Metin Bildiri)

24. Inhibition and Docking Studies of New Pyrimidinyl Acyl Thioureas Compounds as Hsp90

KOCA İ., aykut ö., Er M., GÜMÜŞ M., Coşkun A. K., TUTAR Y.

EuroAsian Biodiversity, 23 - 27 Mayıs 2016, (Tam Metin Bildiri)

25. Designing Heat Shock Protein 70 Inhibitor to Inhibit Cancer Progression Pathways

Coşkun K. A., TUTAR Y.

11th International Conference on Protein Stabilisation, 9 - 11 Mayıs 2016, (Tam Metin Bildiri)

26. Molecular Docking and Antitumoral Activity of Novel Benzoxazines Derivatives in Human Breast Cancer

HEPOKUR C., MISIR S., KOCA İ., TUTAR Y.

11 TH International Conference On Protein Stabilisation, 9 - 11 Mayıs 2016, (Tam Metin Bildiri)

27. Molecular Docking of Novel Pyrazole Derivatives in Human Hsp 70 Inhibition

HEPOKUR C., MISIR S., KOCA İ., TUTAR Y.

11 TH International Conference on Protein Stabilisation, 9 - 11 Mayıs 2016, (Özet Bildiri)

28. Molecular Docking of Novel Pyrazole Derivatives in Human Hsp90 Inhibition

MISIR S., HEPOKUR C., KOCA İ., TUTAR Y.

11TH International Conference on Protein Stabilisation, 9 - 11 Mayıs 2016, (Özet Bildiri)

29. AN EFFICIENT INTERFACE INHIBITOR FOR HSP70 AND ITS COCHAPERONE COMPLEXES

COST ACTION CM1407 2ND MEETING, 4 - 05 Nisan 2016, (Tam Metin Bildiri)

30. Design Synthesis and ANticancer Activity of Novel Acylthioureas with Pyrimidine Core

KOCA İ., Er M., GÜMÜŞ M., Aykut Ö., TUTAR Y.

1st International Turkic World Conference Chemical Sciences and Technology, 27 Ekim - 01 Kasım 2015

31. Farklı Parametrelerde LIPUS Uygulamasının Osteoblast Hücreleri Üzerine Etkisi

COŞKUN M. E., Coşkun K., Özgür A., TUĞUT F., TUTAR Y.

22 Uluslararası Türk Prostodonti ve İmplantoloji Derneği Kongresi, 12 - 15 Kasım 2015, (Özet Bildiri)

32. Designning Substrate Binding Inhibitor for Heat Shock Protein70 as Anticancer Agent

Coşkun K., TUTAR Y.

Natbiochem, 4 - 06 Ekim 2015, (Özet Bildiri)

33. Investigation of human Hsp70 protein inhibition mechanisms for drug designing

3rd Anticancer Agent Development Congress, 18 - 19 Mayıs 2015

34. Inhibition of Heat Shock Response as Anticancer Strategy by Coumarine Compounds

KOCA İ., GÜMÜŞ M., Özgür A., DİŞLİ A., TUTAR Y.

3rd Anticancer Agent Development Congress, 18 - 19 Mayıs 2015, (Özet Bildiri)

35. Synthesis of 1 5 bezodiapezine derivatives as possible biologic active agents

GÜMÜŞ M., KOCA İ., Özgür A., TUTAR Y., DİŞLİ A.

Anatolian Conference on Synthetic Organic Chemistry, 16 - 19 Mart 2015, (Özet Bildiri)

36. Stability and conformational changes in yeast Ssa1 protein

Arslan D., Tutar Y.

cilt.274, ss.301, (Özet Bildiri)

37. Primate chaperones Hsc70 (constitutive) and Hsp70 (induced) differ functionally in supporting growth and prion propagation in Saccharomyces cerevisiae

Tutar Y., Song Y., Masison D.

cilt.273, ss.237, (Özet Bildiri)

38. Ligand binding properties of cAMP receptor protein having amino acid substitutions at positions 72 and 82.

Tutar Y., Harman J.

cilt.84, (Özet Bildiri)

Kitaplar 16

1. Molecular Mechanisms of Breast Cancer Metastasis

Yürekli N., Abay E. C., Tutar M., Cabri E., AÇIKALIN COŞKUN K., KURAL A., et al.

Cancer Metastasis - Molecular Mechanism and Clinical Therapy, Yusuf Tutar, Lütfi Tutar, Editör, Intech, ss.1-21, 2023

2. Introductory Chapter: Molecular Mechanism of Cancer Metastasis

Cancer Metastasis - Molecular Mechanism and Clinical Therapy, Yusuf Tutar, Lütfi Tutar, Editör, Bentham, ss.1-3, 2023

3. 44 Current Challenges in miRNomics

AKGÜL B., F Stadler P., J. Hawkins L., Hadj-Moussa H., B. Storey K., ERGİN K., et al.

miRNomics, Jens Allmer, Malik Yousef, Editör, Springer, ss.423-438, 2022

4. MicroRNAs and Heat Shock Proteins in Breast Cancer Biology

YILDIZ M. T., TUTAR L., Irmak Giritlioğlu N., BAYRAM B., TUTAR Y.

miRNomics, Jens Allmer, Malik Yousef, Editör, Springer, ss.293-310, 2022

5. Heat shock proteins in tumor progression and metastasis

TUTAR Y., Naureen H., Ahmad Farooqi A.

Unraveling the Complexities of Metastasis, Ammad Ahmad Farooqi, Muhammad Zahid Qureshi and Uteuliyev Yerzhan Sabitaliyevich, Editör, Elsevier, ss.187-201, 2022

6. MicroRNA Targeting

Ghanbarian H., YILDIZ M. T., TUTAR Y.

miRNomics, Jens Allmer, Malik Yousef, Editör, Springer, ss.105-130, 2022

7. Structure- and Design-Based Difficulties in Recombinant Protein Purification in Bacterial Expression

AÇIKALIN COŞKUN K., Yürekli N., Abay E. C., Tutar M., AL M., TUTAR Y.

Protein Detection, Yusuf Tutar, Editör, IntechOpen, ss.1-20, 2022

8. Role of p53 in Human Cancers

AÇIKALIN COŞKUN K., Tutar M., AL M., Gök Yurttaş A., Abay E. C., Yürekli N., et al.

P53 - A Guardian of the Genome and Beyond, Mumtaz Anwar, Zeenat Farooq, Mohammad Tauseef and Vijay Avin Balaji, Editör, IntechOpen, ss.1-134, 2022

9. Inhibition of Key Protein-Protein Interactions by Small Molecules for Cancer Drug Design

ÖZGÜR A., TUTAR L., GÜMÜŞ M., KOCA İ., Tunoğlu S., Nurdan Yenilmez Tunoğlu E., et al.

Frontiers in Clinical Drug Research - Anti-Cancer Agents, Atta-Ur Rahman, Editör, Bentham Science Publisher, ss.109-141, 2021

10. Heat Shock Protein and Cancer Based Therapies

TUTAR L., nurdan yenilmez tunoğlu e., yeman kıyak b., TUTAR Y.

Heat Shock Proteins, Alexzander A. A. Asea, Punit Kaur, Editör, Springer Nature, Cham, ss.177-201, 2021

11. Nutrients, Bioactive Compounds, and Health Benefits of Functional and Medicinal Beverages

YILMAZ AKYÜZ E., AYTEKİN Ö., BAYRAM B., TUTAR Y.

Nutrients in Beverages, Alexandru Mihai Grumezescu, Alina Maria Holban, Editör, Woodhead Publishing, Cambridge, ss.175-235, 2019

12. Recent Advances in Nutrigenomics: Patent Applications

YILMAZ AKYÜZ E., AYTEKİN Ö., BAYRAM B., TUTAR Y.

Topics in Anti-Cancer Research: Volume 7, Atta-ur-Rahman, Khurshid Zaman, Editör, Bentham, Maryland, ss.202-220, 2018

13. Involvement of miRNAs and Pseudogenes in Cancer.

TUTAR L., Özgür A., TUTAR Y.

MicroRNA and Cancer Methods in Molecular Biology, Wei Wu, Editör, Methods in molecular biology (Clifton, N.J.), San-Francisco, ss.45-66, 2018

14. Isothermal Titration Calorimetry

AYTEKİN Ö., YILMAZ AKYÜZ E., BAYRAM B., tutar e., PENÇE H. H., TUTAR Y.

Essential Techniques for Medical and Life Scientists: A Guide to Contemporary Methods and Current Applications with the Protocols, Yusuf TUTAR, Editör, Bentham, Maryland, ss.92-108, 2018

15. Recent Developments in Anticancer AgentsTargeting Heat Shock Proteins

Aykut Ö., BAYRAM B., TUTAR L., TUTAR Y.

Topics in Anti Cancer Research, Atta-ur-Rahman / Khurshid Zaman , Editör, Bentham, ss.3-22, 2016

16. Toxoplasma gondii and Heat Shock Proteins in Microbial pathogens and strategies for combating them science technology and education

Özgür A., Coşkun K., TUTAR L., Tutar E., TUTAR Y.

Formatex Publication, 2013

Metrikler

Yayın

165

Yayın (WoS)

92

Yayın (Scopus)

93

Atıf (WoS)

1771

H-İndeks (WoS)

21

Atıf (Scopus)

1823

H-İndeks (Scopus)

21

Atıf (Scholar)

1517

H-İndeks (Scholar)

19

Atıf (TrDizin)

1

H-İndeks (TrDizin)

1

Atıf (Sobiad)

185

H-İndeks (Sobiad)

5

Atıf (Diğer Toplam)

2

Toplam Atıf Sayısı

1959

Proje

35

Tez Danışmanlığı

32

Açık Erişim

3

BM Sürdürülebilir Kalkınma Amaçları